Wealthcare Advisory Partners’s Insmed INSM Stock Holding History

Wealthcare Advisory Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$498K	Buy	+4,672	New	+$566K	0.01%	710
2018 Q4	–	Sell	-4,000	Closed	-$81K	–	1240
2018 Q3	$81K	Buy	+4,000	New	+$90.3K	0.01%	372

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Wealthcare Advisory Partners's INSM Position: Q2 2026 in Review

Wealthcare Advisory Partners opened a new position in Insmed (INSM) in Q2 2026: 4,672 shares worth $498K. The stake represents 0.01% of the portfolio and ranks #710 among its holdings. This is a return to the name: Wealthcare Advisory Partners previously reported a position in INSM as recently as Q3 2018.

Wealthcare Advisory Partners first reported a position in INSM in Q3 2018 and has held it in 2 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Wealthcare Advisory Partners held 4,672 shares of Insmed worth $498K as of Q2 2026.
Insmed was a new Wealthcare Advisory Partners position in Q2 2026.
Insmed made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #710 holding.
Wealthcare Advisory Partners first reported a position in Insmed in Q3 2018 and has held it in 2 quarters since.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.